Roche Holding AG
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. Roche Holding AG has collaboration with Gilead Sciences, Inc. for COVID-19; a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza, as well as SemaThera Inc. to develop biologicals for the treatment of diabetic retinopathy and other ischemic retinal diseases; and has collaboration with Affimed N.V to study AFM24 in combination with PD-L1 checkpoint inhibitor in EGFR expressing solid tumors. The company was founded in 1896 and is headquartered in Basel, Switzerland. Show More...
-
Website http://www.roche.com
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 40.30 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 2020-12 TTM Earnings Per Share CHF 1.37 1.38 1.62 1.35 1.28 1.39 1.25 1.53 1.95 2.06 2.06 Dividends CHF 0.82 0.83 0.9 0.99 0.96 1.01 1.03 1.03 1.08 1.09 1.09 Payout Ratio % * 67.2 59.6 54.9 63.3 73.8 77.0 73.0 67.7 62.8 58.4 52.8 Shares Mil 6.808 6.84 6.904 6.904 6.896 6.88 6.88 6.88 6.912 6.92 6.92 Book Value Per Share * USD 1.36 2.33 2.32 2.59 2.54 2.66 3.41 4.07 4.23 5.28 5.91 Free Cash Flow Per Share * USD 1.86 2.02 2.08 1.95 1.61 1.44 1.81 2.07 2.19 2.6 Return on Assets % 15.24 15.1 17.59 13.54 11.71 12.55 11.25 13.53 16.7 16.89 16.89 Financial Leverage (Average) 5.09 4.47 3.22 3.86 3.61 3.21 2.9 2.84 2.54 2.37 2.37 Return on Equity % 86.65 71.75 66.08 48.0 43.7 42.66 34.29 38.84 44.72 41.38 41.38 Return on Invested Capital % 27.77 28.45 31.62 24.52 21.64 22.71 19.99 24.07 29.74 29.47 29.47 Interest Coverage 6.92 7.16 12.02 11.63 11.76 14.58 17.01 20.02 22.0 33.49 33.49 Current Ratio 1.74 1.55 1.85 1.35 1.19 1.27 1.42 1.4 1.3 1.3 1.3 Quick Ratio 1.37 1.21 1.38 0.97 0.81 0.87 1.04 1.06 1.0 0.96 0.96 Debt/Equity 1.94 1.58 0.85 0.99 0.82 0.71 0.59 0.58 0.41 0.31 0.31